Radiofrequency ablation for obstructive hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This trial tests a new treatment that uses radiofrequency energy (similar to heat) to shrink the thickened heart muscle blocking blood flow. It is for people with obstructive hypertrophic cardiomyopathy who have symptoms despite medication and are not able or willing to have heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a type of thickened heart muscle that blocks blood flow (obstructive hypertrophic cardiomyopathy).
- You have symptoms like shortness of breath, chest pain, or fatigue that affect your daily life.
- Your heart blockage is at least 50 mmHg (a measure of pressure) and you are in New York Heart Association class II or higher.
- The thickened part of your heart is at least 15 mm thick.
- You are not eligible for or you choose not to have heart surgery to fix the blockage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
This trial tests a medication called Ademetionine for people with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is thick and blocks blood flow). It aims to see if the drug can help improve symptoms and exercise ability.
This study tests a new combination treatment approach for people with long-standing persistent atrial fibrillation (a type of irregular heartbeat that lasts for years). It aims to see if this approach can help improve symptoms and restore a more normal heart rhythm.
This trial studies surgery that removes part of the thick heart muscle while the heart is still beating to relieve a blockage that makes blood leaving the heart harder. It may help people with hypertrophic obstructive cardiomyopathy whose symptoms persist despite medication.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This study tests a device called a coronary sinus reducer for people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) who still have symptoms like chest pain. The device is placed in a vein of the heart to improve blood flow and reduce symptoms.
Hear when a new Hypertrophic Cardiomyopathy, Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.